Arvinas Inc (ARVN) Stock Price, Quote, News & History

ARVNNASDAQ
$9.08
-0.31-3.3%
At close: Sep 8, 5:00 PM EST
$8.99
-0.09-0.99%
After Hours: 4:00 PM EST

Arvinas (ARVN) Stock Price, Quote, News & History | Benzinga

60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-207.00M
Investing Cash Flow (TTM)
277.90M
Financing Cash Flow (TTM)
-91.50M
Free Cash Flow (TTM)
-208.80M
Capital Expenditure (TTM)
-1.80M
Net Change in Cash (TTM)
-20.60M

Analyst Trends and Forecast

2
Mar
3
May
1
Jun
3
2
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$54.08M
PE Ratio (TTM)
36.08
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
1.99
PB Ratio (TTM)
1.09
Earnings Yield % (TTM)
2.77%
Earnings Yield % (FWD)
-25.16%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$8.60

Company Debt

Total Debt
$300.00K
LT Debt
$300.00K
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$300.00K
Total Cash
$94.30M
Debt to Equity
0.01
Issuance of Debt (TTM)
-$300.00K
Repayment of Debt (TTM)
-$300.00K

Key Statistics

Open
$9.23
Close
$9.08
Volume / Avg.
570.72K / 759.82K
Day Range
$8.97 - $9.34
52 Wk Range
6.97 - 14.51
Market Cap
$587.82M
P/E Ratio
36.08
Dividend Yield
-
Exchange
NASDAQ
RSI
49
Short Interest
7.22%
Days to Cover
3.33

About

Sector
Health Care
Industry
Pharmaceuticals
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-cau...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Arvinas (ARVN) stock?

A

You can purchase shares of Arvinas (NASDAQ:ARVN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Arvinas (ARVN) competitors?

Q

What is the forecast, or price target, for Arvinas (ARVN) stock?

A

Arvinas has a consensus price target of $19.60.

Q

What is the current price for Arvinas (ARVN)?

A

The stock price for Arvinas (NASDAQ: ARVN) is $8.99 last updated September 8, 2026 at 4:00 PM EDT.

Q

Does Arvinas (ARVN) pay a dividend?

A

There are no upcoming dividends for Arvinas.

Q

When is Arvinas (NASDAQ:ARVN) reporting earnings?

A

Arvinas does not have any upcoming earnings scheduled.

Q

Is Arvinas (ARVN) going to split?

A

There is no upcoming split for Arvinas.

Q

What sector and industry does Arvinas (ARVN) operate in?

A

Arvinas is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.